Advertisement

Related Videos

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Peter Clark, MA, MD, FRCP: A Payer Perspective

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Oct
13
Today In Oncology
Prior Authorization Is Burdensome for Patients, Resulting in Treatment Delays, Financial Strain, and Stress
Antidepressants May Improve Surgical Outcomes in Patients With GI Cancer and Depression
Patients Value Communication Skills From Cancer Surgeons Across Six Key Areas
Study Identifies Rectal Bleeding as Key Predictor of Early-Onset Colorectal Cancer
Financial Toxicity Tied to Increased Risk of Mortality Among Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo